Mayer EL, Abramson V, Jankowitz R, Falkson C, et al. TBCRC 030: A phase II study of preoperative cisplatin vs. paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker. Ann Oncol 2020 Aug 13. pii: S0923-7534(20)42061.
PMID: 32798689